Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | PAHC |
---|---|---|
09:32 ET | 5835 | 24.115 |
09:33 ET | 300 | 23.98 |
09:37 ET | 200 | 24.03 |
09:42 ET | 100 | 23.94 |
09:44 ET | 100 | 23.92 |
09:48 ET | 400 | 23.9 |
09:50 ET | 200 | 23.9 |
09:51 ET | 400 | 23.905 |
09:53 ET | 300 | 24.04 |
09:55 ET | 200 | 23.96 |
10:00 ET | 5478 | 24.055 |
10:02 ET | 2386 | 24 |
10:04 ET | 914 | 23.8712 |
10:06 ET | 200 | 23.92 |
10:13 ET | 100 | 23.99 |
10:15 ET | 1200 | 24.035 |
10:18 ET | 125 | 24.025 |
10:20 ET | 100 | 24.02 |
10:22 ET | 100 | 23.94 |
10:24 ET | 1300 | 23.97 |
10:27 ET | 300 | 23.935 |
10:29 ET | 675 | 23.8 |
10:36 ET | 746 | 23.7206 |
10:38 ET | 100 | 23.72 |
10:40 ET | 200 | 23.75 |
10:44 ET | 700 | 23.81 |
10:45 ET | 1200 | 23.75 |
10:47 ET | 200 | 23.7733 |
10:49 ET | 100 | 23.7 |
10:51 ET | 100 | 23.81 |
10:54 ET | 1326 | 23.77 |
10:58 ET | 100 | 23.79 |
11:00 ET | 100 | 23.765 |
11:03 ET | 1074 | 23.795 |
11:05 ET | 548 | 23.78 |
11:12 ET | 200 | 23.71 |
11:14 ET | 100 | 23.7325 |
11:16 ET | 100 | 23.735 |
11:18 ET | 730 | 23.73 |
11:20 ET | 715 | 23.765 |
11:23 ET | 1597 | 23.79 |
11:32 ET | 320 | 23.85 |
11:34 ET | 100 | 23.82 |
11:36 ET | 600 | 23.74 |
11:45 ET | 263 | 23.74 |
11:52 ET | 1336 | 23.74 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Phibro Animal Health Corp | 961.6M | 55.3x | -46.35% |
Supernus Pharmaceuticals Inc | 2.0B | 33.9x | -59.02% |
Eagle Pharmaceuticals Inc | 12.3M | 0.9x | -4.75% |
Elite Pharmaceuticals Inc | 658.9M | -104.9x | --- |
Shengtai Pharmaceutical Inc | 10.0 | 0.0x | --- |
Medicine Man Technologies Inc | 6.2M | --- | --- |
Phibro Animal Health Corporation is a global diversified animal health and mineral nutrition company. It develops, manufactures and markets a range of products for food and companion animals, including poultry, swine, beef and dairy cattle, aquaculture and dogs. It markets approximately 750 product lines in over 80 countries to approximately 4,200 customers. It has three segments: Animal Health, Mineral Nutrition and Performance Products. Its Animal Health segment develops, manufactures and markets about 280 product lines, including antibacterials, anticoccidials and related products; nutritional specialty products; and vaccines. The Mineral Nutrition segment is comprised of formulations and concentrations of trace minerals such as zinc, manganese, copper, iron and other compounds, with a focus on customers in North America. The Performance Products segment manufactures and markets specialty ingredients for use in the personal care, industrial chemical and chemical catalyst industries.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $961.6M |
---|---|
Revenue (TTM) | $1.0B |
Shares Outstanding | 40.5M |
Dividend Yield | 2.02% |
Annual Dividend Rate | 0.4800 USD |
Ex-Dividend Date | 11-27-24 |
Pay Date | 12-18-24 |
Beta | 0.51 |
EPS | $0.43 |
Book Value | $6.34 |
P/E Ratio | 55.3x |
Price/Sales (TTM) | 0.9 |
Price/Cash Flow (TTM) | 17.9x |
Operating Margin | 6.85% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.